Skip to content
A

Aisha Elaimi

Publications (3)

Calreticulin and JAK2 Exon 12 Mutation Screening in Patients with Myeloproliferative Neoplasms’ in Jeddah Region, Saudi Arabia

Heba Alkhatabi, Heyam Abdulqayoom, Raed Alserihi, Raed Felimban, Aisha Elaimi, Zinab Allala, Afaf Magboli, Salem Bahashwan, Hashem Alsalmi, Abdulelah Shihah, Adel Abuzenadah & Elrashed B. Yasin · Journal of Pharmaceutical Research International · 2021

Background: The JAK2 V617F mutation’s discovery has largely facilitated the comprehension of the myeloproliferative neoplasms’(MPNs) pathogenesis. In recent times, calreticulin (CALR) mutations have been detected in patients with JAK2V617F negative primary myelofibrosis (PMF), an...

Open access Research Article 10.9734/jpri/2021/v33i47A33029

The Correlation between Gene Expression and DNA Methylation Levels of RAS p21 Protein Activator 3 (RASA3) Gene in Saudi Autistic Children

Aisha Alrofaidi, Rawan Saeed Alghamdi, Mona Alharbi, Khloud Algothmi, Reem Farsi, Najla Alburae, Magdah Ganash, Fatemah Basingab, Sheren Azhari, Heba Alkhatabi, Aisha Elaimi, Manal Shaabad, Ashraf Dallol, Amany Alqosaibi, Mohammed Jan, Hesham Aldhalaan & Safiah Alhazmi · Journal of Pharmaceutical Research International · 2021

The potential role of DNA methylation pattern in autism has been provided by revealing the differences in methylation level of multiple genes which are significantly associated with their expression and implicated in ASD pathogenesis. RASA3 is a member of GTPase-activating protei...

Open access Research Article 10.9734/jpri/2021/v33i33B31794